PT - JOURNAL ARTICLE AU - Fernando B Serra AU - Diogo Ribeiro AU - Paula M Batista AU - Thais N F Moreira TI - Adult vaccination in Brazil: a cross-sectional survey on physicians’ prescription habits AID - 10.1101/2021.02.02.21251016 DP - 2021 Jan 01 TA - medRxiv PG - 2021.02.02.21251016 4099 - http://medrxiv.org/content/early/2021/02/03/2021.02.02.21251016.short 4100 - http://medrxiv.org/content/early/2021/02/03/2021.02.02.21251016.full AB - OBJECTIVE To characterize adult and older adult vaccination practices of physicians from various medical specialties in Brazil, identify the barriers influencing prescription of vaccines to these populations, and evaluate the physicians’ knowledge on routinely prescribed vaccines.METHODS Cross-sectional survey conducted in Brazil between June-August 2018. Eligible physicians included those from general practice/family medicine, geriatrics, cardiology, gynecology, endocrinology, infectious disease and pulmonology. The survey’s questions addressed the physicians’ prescription habits, sociodemographic and clinical practice characteristics, barriers to vaccines’ prescription to adult and older adult patients, and physicians’ knowledge regarding routinely prescribed vaccines. The study focused on the vaccines recommended by the Brazilian Society of Immunization (SBIm) for adults and older adults. Study sample was stratified according to the number of physicians per specialty and Brazilian region.RESULTS A total of 1068 surveys were completed. The vaccines prescribed by the highest proportions of physicians were Influenza (>90% of physicians for adults and older adults), Hepatitis B (adults: 87%; older adults: 59%) and Yellow Fever (adults: 77.7%; older adults: 58.5%). Underprescription was reported by less than 20% of prescribing physicians for all adult and older adult recommended vaccines. The most common barriers to vaccination were the high vaccine cost, lack of time during appointments and lack of patient interest. Knowledge on target populations, dosage schedule and availability in the Unified Public Health System (SUS) was generally low.CONCLUSIONS The results showed a considerable variability of prescribing habits across recommended vaccines and medical specialties. Although most prescribing physicians seem to be aware of the importance of adult and older adults vaccination, knowledge deficits on vaccines’ target populations, dosage schedule and availability in the SUS may hamper their ability to prescribe vaccines to all patients with an indication.Competing Interest StatementFernando B Serra, Paula M Batista and Thais N F Moreira are employees of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ USA, who may own stock and/or hold stock options in Merck & Co., Inc., Kenilworth, NJ, USA. Diogo Ribeiro is an employee of CTI Clinical Trial & Consulting Services. This company received honoraria from the project funder for support in the study planning and manuscript development.Funding StatementFernando B Serra, Paula M Batista and Thais N F Moreira are employees of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ USA, who may own stock and/or hold stock options in Merck & Co., Inc., Kenilworth, NJ, USA. Diogo Ribeiro is an employee of CTI Clinical Trial & Consulting Services. This company received honoraria from the project funder for support in the study planning and manuscript development.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the Ethics Committee of Universidade Federal de Sao PauloAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yesnot applicable.